Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Discover wealth growth examples over 10 years to understand investment potential. Start your journey to wealth today.
26,947 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Markets toppled and surged in swings as investors assessed a policy path that some say appears improvised. Analysts w...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
If federal foreclosure protections vanish, the housing market could see a surge of distressed properties. This articl...
Nokia's CEO warns that companies using AI must rethink work processes as automation turns ideas into action faster, r...
AI disruption is reshaping entry-level jobs, pushing the next generation to consider space-based careers. This report...
Microsoft accelerates its AI push to reclaim leadership as market re-pricing tests margins. Nadella reshapes teams an...
KBWD distributes roughly 12% annually by investing in business development companies that lend to mid-market firms. I...
PulteGroup opens its first Florida Del Webb Explore community in Parrish, delivering multigenerational, resort-style ...
Intel shares jumped on a new Hitachi pact, fueling speculation that Google and NVIDIA could lean on Intel Foundry for...
FEZ investors see lumpy payouts tied to eurozone dividend calendars. This piece breaks down what that means for incom...